Fenbendazole (FBZ) is an anthelmintic drug that is used to treat parasitic infections in animals. Its anti-cancer effect has been reported in cancer cell culture experiments and animal studies, but it hasn’t yet shown significant clinical effects in human patients. However, a celebrity’s claim that he was in remission from lung cancer after taking fenbendazole has increased the drug’s popularity in the media. We interviewed 21 people with lung cancer to examine the channels they acquired fenbendazole and general cancer information through, the quality of the obtained information, and their perceptions toward it.
FBZ interferes with the formation of microtubules, which are like little ropes that help cells move things around inside them. It is also known to inhibit sugar uptake in cancer cells, preventing them from absorbing the energy they need to grow and reproduce. This is one of the reasons why it has been praised for its ability to prevent tumor growth.
According to the latest research, fenbendazole is also an effective drug for treating pancreatic cancer. Gregory Riggins, a neurosurgeon at Johns Hopkins University School of Medicine, and his team found that fenbendazole could slow or stop the spread of early and advanced pancreatic cancer in mice. Their findings were published in Oncotarget on July 6. Earlier studies had shown that the drug mebendazole, which is similar to fenbendazole, can slow or kill pancreatic cancer by reducing inflammation and blocking signaling pathways that promote tumour growth.
The team also found that fenbendazole works by cutting off the supply of energy to cancer cells, which are unable to repair damaged DNA. It works by preventing tubulin, a protein that forms the structure and shape of the inner cell, from being assembled into a long filament. The resulting collapsed tubulin starves the cancer cell, killing it.
The team believes that the key to successful medical education is to teach people the importance of obtaining information from credible sources and to actively cross-check it. Specifically, health authorities should have an efficient communication system that can promptly deliver evidence-based information to the public. It is especially important for doctors to provide clear, accurate information about controversial medical treatments. In addition, they should avoid using the Internet as a channel for disseminating false information. It is also essential to keep up-to-date with the latest developments in cancer research, and to use alternative treatments as complementary therapy only when approved by physicians. This will allow them to provide more comprehensive care for patients with different needs. fenbendazole cancer treatment